D. E. Shaw & Co., Inc. Cue Biopharma, Inc. Transaction History

D. E. Shaw & Co., Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$3.11 - $4.91 $114,077 - $180,103	36,681 New	36,681 $133,000
Q1 2020 May 15, 2020	SELL	$9.85 - $22.27 $127,143 - $287,461	-12,908 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$7.06 - $17.47 $91,130 - $225,502	12,908 New	12,908 $205,000

14.1M

14.4K

2.6K

Ticker CUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,381,700
Market Cap $38.2M
Description
Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to target an...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.